返回 Agenda
Session Chair(s)
Robert Hemmings, MSC
Critical Path Institute, Netherlands
Speaker(s)
Recurrent Event Data Approaches in Cardiovascular Outcome Trials
Mouna Akacha, PHD
Novartis Pharma AG, Switzerland
Group Head of Statistical Methodology
Feedback from the EMA 2012 Workshop on Multiplicity Issues in Clinical Trials
Norbert Benda, PHD
Federal Institute For Drugs and Medical Devices (BfArM), Germany
Head of Biostatistics and Special Pharmacokinetics
Clinical Development Considerations when Different Agencies Require Different Primary Endpoints
David Wilson
AstraZeneca, United Kingdom
Statistical Science Director